CLINICAL_TRIALS
trial_result
· 2016-05-26
Clinical Trial Update: A Study of LY2439821 in Rheumatoid Arthritis [Phase 1]
Summary
A Phase 1 clinical trial of LY2439821 in rheumatoid arthritis has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED | Results posted: 2016-05-26